| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| A795452 | MACKLIN | 别嘌醇 | 10mM in DMSO | 428元/1ml; | 咨询 |
|
| A800424 | MACKLIN | 别嘌醇 | 98% | 38元/25g; 118元/100g; 498元/500g; 2398元/2.5kg; | 咨询 |
|
| A0907 | TCI | Allopurinol | >98.0%(T) | 490元/25G; 1100元/250G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T) | | 分子式/分子量 | C5H4N4O = 136.11 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 608611 | | PubChem物质ID | 87562416 | | SDBS (AIST Spectral DB) | 4122 | | Merck Index (14) | 279 | | MDL编号 | MFCD00599413 |
技术规格 | Appearance | White to Light yellow powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Neutralization titration) | min. 98.0 % | | Solubility in 1mol/L NaOH | almost transparency |
物性(参考值) | 熔点 | 384 ℃ | | 水溶性 | 不溶 | | 在水中的溶解度 | 0.48 g/l 25 ℃ | | 溶解性(不溶于) | 氯仿,乙醇,乙醚 |
安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
H317 : 可能造成皮肤过敏反应。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P261 : 避免吸入粉尘/烟/气体/烟雾/蒸气/喷雾。
P272 : 受沾染的工作服不得带出工作场地。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套。
P302 + P352 : 如皮肤沾染：用水充分清洗。
P362+P364 : 脱掉沾污的衣服，清洗后方可重新使用。
P333 + P313 : 如发生皮肤刺激或皮疹：求医/就诊。
P301 + P310 + P330 : 如误吞咽：立即呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| 204337 | J&K | Allopurinol | 98% | 149元/25G; 475元/100G; 1897元/500G; | 咨询 |
基本信息 | 分子式 | C5H4N4O | | 分子量 | 136.11 | | 熔点 | >300 | | MDL编码 | MFCD00599413 | | Merck | 14,279 | | EINECS 编号 | 206-250-9 |
安全信息 | 图形或危害标志 | | | 提示语 | Danger | | 危险说明 | H301
H317 | | 防范说明 | P280
P301+P310 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | WGK | 2 | | RTECS | UR0785000 | | TSCA | 是 |
|
| A16974 | Alfa Aesar | 4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine | 98% | 846元/5g; 1705元/25g; | 咨询 |
应用
Xanthine oxidase inhibitor; decreases uric acid production 基本信息 MDL
MFCD00599413 EINECS
206-250-9 分子式
C5H5N4O 分子量
136.11 熔点
>300° 灵敏度
Ambient temperatures. 形态
Powder GHS危害和防范说明 GHS符号
Hazard Statements
H301-H317
Toxic if swallowed.May cause an allergic skin reaction. Precautionary Statements
P261-P280g-P301+P310a-P321-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray.Wear protective gloves.Wear protective gloves.Specific treatment (see label).Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险等级
6.1 包装组
III 危险类别
25-43
Toxic if swallowed.May cause sensitization by skin contact. 安全等级
24-36/37-45
Avoid contact with skin.Wear suitable protective clothing and gloves.In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). TSCA
是 |
| C12183 | Alfa Aesar | Allopurinol | 98% | 537元/5g; 1282元/25g; 3502元/100g; | 咨询 |
基本信息 Ref#
12183 MDL
599413 分子式
C5 H4 N4 O 分子量
136.11 安全信息 危险等级
6.1 包装组
III |
| A8003 | Sigma-Aldrich | Allopurinol | xanthine oxidase inhibitor | 902.67元/5 G; 3448.53元/25 G; | 咨询 |
产品说明 包装 5, 25 g in glass bottle 生化/生理作用 黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。 基本信息 | 经验(实验)分子式 | C5H4N4O | | 分子量 | 136.11 | | EC 号 | 206-250-9 | | MDL编号 | MFCD00599413 | | PubChem化学物质编号 | 24278141 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 生物来源 | synthetic (organic) | | 测定 | ≥99% (TLC) | | 形式 | powder | | mp | >300 ℃ (lit.) | | 溶解性 | 1 M NaOH: soluble 50 mg/mL, clear to very slightly hazy, colorless to faintly yellow | | 储存温度 | room temp | | SMILES string | O=C1NC=Nc2[nH]ncc12 | | InChI | 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) | | InChI key | OFCNXPDARWKPPY-UHFFFAOYSA-N | | Gene Information | human ... XDH(7498) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 - H317 | | 预防措施声明 | P280 - P301 + P310 + P330 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| PHR1377 | Supelco | Allopurinol | Pharmaceutical Secondary Standard; Certified Reference Material | 1359.83元/1 G; | 咨询 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Allopurinol is a drug used in the treatment of chronic gout or hyperuricaemia. Its mode of action involves inhibition of xanthine oxidase, an important enzyme catalyzing the hydroxylation of hypoxanthine to xanthine and xanthine to uric acid. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Allopurinol may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by spectrophotometry. 生化/生理作用 黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。 分析说明 These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA1633 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C5H4N4O | | 分子量 | 136.11 | | EC 号 | 206-250-9 | | MDL编号 | MFCD00599413 | | PubChem化学物质编号 | 329823354 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material
pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable
gas chromatography (GC): suitable | | mp | >300 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 870
traceable to PhEur A0350000
traceable to USP 1013002 | | 储存温度 | 2-30℃ | | SMILES string | O=C1NC=Nc2[nH]ncc12 | | InChI | 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) | | InChI key | OFCNXPDARWKPPY-UHFFFAOYSA-N | | Gene Information | human ... XDH(7498) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 - H317 | | 预防措施声明 | P280 - P301 + P310 + P330 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| A0350000 | | Allopurinol | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C5H4N4O | | 分子量 | 136.11 | | MDL编号 | MFCD00599413 | | PubChem化学物质编号 | 329770603 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | >300 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | O=C1NC=Nc2[nH]ncc12 | | InChI | 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) | | InChI key | OFCNXPDARWKPPY-UHFFFAOYSA-N | | Gene Information | human ... XDH(7498) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 - H317 | | 预防措施声明 | P280 - P301 + P310 + P330 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1013002 | USP | Allopurinol | United States Pharmacopeia (USP) Reference Standard | 3231.47元/250 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C5H4N4O | | 分子量 | 136.11 | | MDL编号 | MFCD00599413 | | PubChem化学物质编号 | 329748958 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | >300 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 15-25℃ | | SMILES string | O=C1NC=Nc2[nH]ncc12 | | InChI | 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) | | InChI key | OFCNXPDARWKPPY-UHFFFAOYSA-N | | Gene Information | human ... XDH(7498) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 - H317 | | 预防措施声明 | P261 - P264 - P270 - P280 - P301 + P310 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Skin Sens. 1 | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP870 | | Allopurinol | British Pharmacopoeia (BP) Reference Standard | 146.03元/200 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。 包装 Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C5H4N4O | | 分子量 | 136.11 | | EC 号 | 206-250-9 | | MDL编号 | MFCD00599413 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | >300 ℃ (lit.) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | O=C1NC=Nc2[nH]ncc12 | | InChI | 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) | | InChI key | OFCNXPDARWKPPY-UHFFFAOYSA-N | | Gene Information | human ... XDH(7498) |
安全信息 | 象形图 | | | 警示用语： | Danger | | 危险声明 | H301 - H317 | | 预防措施声明 | P280 - P301 + P310 + P330 - P302 + P352 | | 危险分类 | Acute Tox. 3 Oral - Skin Sens. 1 | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 069190 | Fluorochem | 1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one | 97% | 220元/1g; 242元/25g; 572元/100g; 1804元/500g; | 咨询 |
基本信息 | CAS Number | 315-30-0 | | MDL Number | MFCD00599413 | | Melting Point | >300℃ |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H301: Toxic if swallowed.
H315: Causes skin irritation.
H317: May cause an allergic skin reaction.
H319: Causes serious eye irritation.
H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed.
P260: Do not breathe .
P261: Avoid breathing
P264: Wash hands thoroughly after handling.
P270: Do not eat, drink or smoke when using this product.
P271: Use only outdoors or in a well-ventilated area.
P272: Contaminated work clothing should not be allowed out of the workplace.
P280: Wear .
P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P302 + P352: IF ON SKIN: Wash with plenty of soap and water.
P304: IF INHALED: .
P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P312: Call a POISON CENTER or doctor/physician if you feel unwell.
P321: Specific treatment (see . on this label).
P330: Rinse mouth.
P332 + P313: If skin irritation occurs: Get medical advice/ attention.
P333 + P313: If skin irritation or rash occurs: Get medical advice/attention.
P337 + P313: If eye irritation persists: Get medical advice/attention.
P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P362: Take off contaminated clothing and wash before reuse.
P363: Wash contaminated clothing before reuse.
P403: Store in a well-ventilated place.
P403 + P233: Store in a well-ventilated place. Keep container tightly closed.
P405: Store locked up.
P501: Dispose of contents/container to local regulations.
|
|
m.cnreagent.com